CD8A and coinfection: If HIV-1 and HTLV-2 coinfection occurred simultaneously, HTLV-2 may be preventing the decrease in cytotoxic potential of HIV-1 specific CD8+ T cells along with disease progression and/or favoring the restoration of their cytotoxicity during antiretroviral therapy.